<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23856384</PMID><DateCompleted><Year>2014</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN><JournalIssue CitedMedium="Internet"><Volume>176</Volume><Issue>1-2</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Virus research</Title><ISOAbbreviation>Virus Res</ISOAbbreviation></Journal><ArticleTitle>A study of the virulence in mice of high copying fidelity variants of human enterovirus 71.</ArticleTitle><Pagination><StartPage>265</StartPage><EndPage>272</EndPage><MedlinePgn>265-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2013.06.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-1702(13)00222-0</ELocationID><Abstract><AbstractText>Polioviruses with a G64S mutation in the 3D polymerase have enhanced replication fidelity and are attenuated in animal models. Here we describe the mouse virulence properties of high replication fidelity 3D polymerase variants of human enterovirus 71 (HEV71), with mutations at positions 3D-S264L, 3D-G64R or at 3D-S264L plus 3D-G64R. Mouse-adapted strains (MP-G64R, MP-S264L and MP-S264L-G64R) were constructed in order to compare the virulence of the 3D polymerase variants with that of mouse-adapted parental virus (MP-26M). MP-S264L and MP-S264L-G64R were attenuated in mice (mean survival time 7.0 and 7.5 days p.i., respectively) compared to MP-G64R and MP-26M (mean survival time 6.5 and 6.0 days p.i., respectively). MP-26M and MP-G64R infection induced early onset, severe generalised necrotising myositis, whereas MP-S264L and MP-S264L-G64R infection induced a later onset, mild and focal skeletal muscle myositis. Our findings demonstrate that only the 3D-S264L mutation attenuates HEV71 in mice, suggesting that the high replication fidelity phenotype is not essential for virulence attenuation in this model.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadeghipour</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infectious Diseases and Immunology, Sydney Medical School, Blackburn Building D06, The University of Sydney, NSW 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMinn</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virus Res</MedlineTA><NlmUniqueID>8410979</NlmUniqueID><ISSNLinking>0168-1702</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber><NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000825" MajorTopicYN="N">Animal Structures</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012324" MajorTopicYN="N">RNA-Dependent RNA Polymerase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>7</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23856384</ArticleId><ArticleId IdType="pmc">PMC7114468</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2013.06.019</ArticleId><ArticleId IdType="pii">S0168-1702(13)00222-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Castro C., Smidansky E.D., Arnold J.J., Maksimchuk K.R., Moustafa I., Uchida A., Gotte M., Konigsburg W., Cameron C.E. Nucleic acid polymerases use a general acid for nucleotidyl transfer. Nature Structural Biology. 2009;16(2):212&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2728625</ArticleId><ArticleId IdType="pubmed">19151724</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua B.H., Phuektes P., Sanders S.A., Nicholls P.K., McMinn P.C. The molecular basis of mouse adaptation by human enterovirus 71. Journal of General Virology. 2008;89(7):1622&#x2013;1632.</Citation><ArticleIdList><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffey L.L., Vignuzzi M. Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures. Journal of Virology. 2011;85(2):1025&#x2013;1035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3020036</ArticleId><ArticleId IdType="pubmed">21047966</ArticleId></ArticleIdList></Reference><Reference><Citation>Gn&#xe4;dig N.F., Beaucourt S., Campagnola G., Border&#xed;a A.V., Sanz-Ramos M., Gong P., Blanc H., Peersen O.B., Vignuzzi M. Coxsackievirus B3 mutator strains are attenuated in vivo. Proceedings of the National Academy of Sciences. 2012;109(34):E2294&#x2013;E2303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427060</ArticleId><ArticleId IdType="pubmed">22853955</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham R., Becker M., Eckerle L., Bolles M., Denison M., Baric R. A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nature Medicine. 2012;18(12):1820&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3518599</ArticleId><ArticleId IdType="pubmed">23142821</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles N.J., Hovi T., Hyypi&#xe4; T., King A.M.Q., Lindberg A.M., allansch M.A., Palmenberg A.C., immonds P., kern T., Stanway G., Yamashita T., Zell R. Virus Taxonomy: Classification and Nomenclature of Viruses. Elsevier; San Diego: 2012. Picornaviridae.</Citation></Reference><Reference><Citation>Liu J., Dong W., Quan X., Ma C., Qin C., Zhang L. Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Archives of Virology. 2012;157(3):539&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">22187102</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiology Review. 2002;26(1):91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Stratov I., Nagarajan L., Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in western Australia. Clinical Infectious Diseases. 2001;32(2):236&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N., Shimizu H., Ami Y., Tano Y., Harashima A., Suzaki Y., Sato Y., Miyamura T., Sata T., Iwasaki T. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. Journal of Medical Virology. 2002;67(2):207&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11992581</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nature Medicine. 2009;15(7):794&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer J.K., Kirkegaard K. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proceedings of the National Academy of Sciences. 2003;100(12):7289&#x2013;7294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165868</ArticleId><ArticleId IdType="pubmed">12754380</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer J.K., Kirkegaard K. Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathogens. 2005;1(2):e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1250929</ArticleId><ArticleId IdType="pubmed">16220146</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology. 1938;27(3):493&#x2013;497.</Citation></Reference><Reference><Citation>Ren R., Costantini F., Gorgacz E.J., Lee J.J., Racaniello V.R. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell. 1990;63(2):353&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">2170026</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghipour S., Bek E.J., McMinn P.C. Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture. Journal of Virology. 2013;87(3):1759&#x2013;1769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554166</ArticleId><ArticleId IdType="pubmed">23175376</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz-Ramos M., D&#xed;az-San Segundo F., Escarm&#xed;s C., Domingo E., Sevilla N. Hidden virulence determinants in a viral quasispecies in vivo. Journal of Virology. 2008;82(21):10465&#x2013;10476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2573215</ArticleId><ArticleId IdType="pubmed">18715925</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz-Ramos M., Rodr&#xed;guez-Calvo T., Sevilla N. Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population. PLoS ONE. 2012;7(6):e39941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3386257</ArticleId><ArticleId IdType="pubmed">22761933</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignuzzi M., Stone J.K., Arnold J.J., Cameron C.E., Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature. 2006;439(7074):344&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569948</ArticleId><ArticleId IdType="pubmed">16327776</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignuzzi M., Wendt E., Andino R. Engineering attenuated virus vaccines by controlling replication fidelity. Nature Medicine. 2008;14(2):154&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">18246077</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks S.A., Lee C.A., Zhao Y., Smidansky E.D., August A., Arnold J.J., Cameron C.E. A polymerase mechanism-based strategy for viral attenuation and vaccine development. Journal of Biological Chemistry. 2012;287(38):31618&#x2013;31622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3442494</ArticleId><ArticleId IdType="pubmed">22854962</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright A.J., Phillpotts R.J. Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection of mice. Archives of Virology. 1998;143(6):1155&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">9687872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nature Medicine. 2009;15(7):798&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z., McMinn P. A single mutation in capsid protein VP1 (Q145E) of a genogroup C4 strain of human enterovirus 71 generates a mouse-virulent phenotype. Journal of General Virology. 2012;93(Pt 9):1935&#x2013;1940.</Citation><ArticleIdList><ArticleId IdType="pubmed">22647370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z., Phuektes P., McMinn P. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1. Virus Research. 2012;167(1):86&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">22575826</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>